| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 74898* | 2016 |
| 2020 International Society of Hypertension global hypertension practice guidelines T Unger, C Borghi, F Charchar, NA Khan, NR Poulter, D Prabhakaran, ... Hypertension 75 (6), 1334-1357, 2020 | 4878 | 2020 |
| International union of pharmacology. XXIII. The angiotensin II receptors M De Gasparo, KJ Catt, T Inagami, JW Wright, TH Unger Pharmacological reviews 52 (3), 415-472, 2000 | 2946 | 2000 |
| Atrial natriuretic factor—a circulating hormone stimulated by volume loading RE Lang, H Thölken, D Ganten, FC Luft, H Ruskoaho, TH Unger Nature 314 (6008), 264-266, 1985 | 1551 | 1985 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 1306 | 2021 |
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised … Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ... The Lancet 372 (9644), 1174-1183, 2008 | 1256 | 2008 |
| The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. M Stoll, UM Steckelings, M Paul, SP Bottari, R Metzger, T Unger The Journal of clinical investigation 95 (2), 651-657, 1995 | 1146 | 1995 |
| Angiotensin type 1 receptor blockers induce peroxisome proliferator–activated receptor-γ activity M Schupp, J Janke, R Clasen, T Unger, U Kintscher Circulation 109 (17), 2054-2057, 2004 | 1088 | 2004 |
| Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C T difference” formula JH Schefe, KE Lehmann, IR Buschmann, T Unger, H Funke-Kaiser Journal of molecular medicine 84, 901-910, 2006 | 1076 | 2006 |
| Angiotensin II type 1–receptor activating antibodies in renal-allograft rejection D Dragun, DN Müller, JH Bräsen, L Fritsche, M Nieminen-Kelhä, ... New England Journal of Medicine 352 (6), 558-569, 2005 | 1024 | 2005 |
| T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance U Kintscher, M Hartge, K Hess, A Foryst-Ludwig, M Clemenz, M Wabitsch, ... Arteriosclerosis, thrombosis, and vascular biology 28 (7), 1304-1310, 2008 | 923 | 2008 |
| Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. W Linz, G Wiemer, P Gohlke, T Unger, BA Schölkens Pharmacological reviews 47 (1), 25-49, 1995 | 843 | 1995 |
| The role of the renin-angiotensin system in the development of cardiovascular disease T Unger The American journal of cardiology 89 (2), 3-9, 2002 | 731 | 2002 |
| Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. EC Fletcher, J Lesske, W Qian, CC Miller 3rd, T Unger Hypertension 19 (6_pt_1), 555-561, 1992 | 655 | 1992 |
| Angiotensin AT1/AT2 receptors: regulation, signalling and function E Kaschina, T Unger Blood pressure 12 (2), 70-88, 2003 | 617 | 2003 |
| Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea EC Fletcher, J Lesske, R Behm, CC Miller 3rd, H Stauss, T Unger Journal of applied physiology 72 (5), 1978-1984, 1992 | 554 | 1992 |
| AT2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism P Gohlke, C Pees, T Unger Hypertension 31 (1), 349-355, 1998 | 531 | 1998 |
| The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data VJ Dzau, K Bernstein, D Celermajer, J Cohen, B Dahlöf, J Deanfield, ... The American journal of cardiology 88 (9), 1-20, 2001 | 518 | 2001 |
| Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled P Bramlage, D Pittrow, HU Wittchen, W Kirch, S Boehler, H Lehnert, ... American journal of hypertension 17 (10), 904-910, 2004 | 466 | 2004 |
| Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism D Westermann, S Rutschow, S Jäger, A Linderer, S Anker, A Riad, ... Diabetes 56 (3), 641-646, 2007 | 429 | 2007 |
